The current Board, which has overseen $1 billion of shareholder value destruction, and which has presided over an eye-watering 99% share price decline ... s role at Purdue Pharma, or of Purdue ...

(“MediPharm”, “MediPharm Labs”, or the “Company”), owning approximately 3% of the Company’s common stock, today issued a statement regarding CEO David Pidduck’s background as former CEO & President of ...

The pharma stock has delivered multibagger returns of 254% in the past five years. At 9:25 AM, Sun Pharma share price was trading 3.78% lower at ₹1,655.00 apiece on the BSE. Disclaimer ...

JPMorgan cuts Mankind Pharma stock price target to INR2,900 ...

(Reuters) - A former McKinsey & Co partner was sentenced on Thursday to six months in prison for obstructing justice by destroying records related to advice the consulting firm gave Purdue Pharma ...

Sun Pharma’s board has proposed a final dividend of Rs 5.5 per ... most brokerage firms slashed their target prices while retaining positive ratings for the stock. Citi increased its target on the ...

UroGen Pharma Ltd.URGN shares traded lower Wednesday ... their review of the application for UGN-102.” URGN Price Action: UtroGen stock closed 44.69% lower at $4.17, according to data from ...

On Thursday, JPMorgan (NYSE: JPM) analysts revised the price target for Mankind Pharma Ltd (MANKIND:IN), reducing it to INR2,900 from the previous INR3,150.Despite this adjustment, the firm retains an ...

Ex-McKinsey Partner Who Advised Opioid Maker Purdue Pharma Sentenced to Prison By Nate Raymond (Reuters) - A former McKinsey & Co partner was sentenced on Thursday to six months in prison for ...

(Reuters) - A former McKinsey & Co partner was sentenced on Thursday to six months in prison for obstructing justice by destroying records related to advice the consulting firm gave Purdue Pharma on ...

On Wednesday, JPMorgan (NYSE: JPM) updated its stance on Torrent Pharma (TRP:IN), revising the company’s price target to INR 3,650 from INR 3,700, while sustaining a Neutral stock rating.The ...